Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
3. 46
-0.7
-16.7067%
$
2.23B Market Cap
- P/E Ratio
- Div Yield
40.59M Volume
-1.72 Eps
$ 4.16
Previous Close
Add Transaction
Day Range
3.44 4.18
Year Range
2.77 7.18
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Recursion Pharmaceuticals, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Heather LeVar
Heather LeVar Roxbury Financial LLC
1,000 $4,130 $3,605 -$525 -12.71%
FG
Fabian Guerra Guerra Advisors Inc.
1,000 $4,880 $4,365 -$515 -10.55%
AssuredPartners Investment Advisors LLC
AssuredPartners Investment Advisors LLC AssuredPartners Investment Advisors LLC
33,546 $130,444.47 $120,933.33 -$9,511.14 -7.29%
PR
Philippe Reitzer Banque Transatlantique SA
924 $5,003.94 $3,284.82 -$1,719.12 -34.36%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
11,043 $64,459.02 $38,816.14 -$25,642.88 -39.78%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
257,658 $1.22M $1.07M -$147,092.4 -12.07%
Ameriflex Group Inc.
Ameriflex Group Inc. Ameriflex Group Inc.
2,000 $8,303.32 $8,320 $16.68 0.2%
Corinne Lafaurie-Konter
Corinne Lafaurie-Konter 111 Capital
26,198 $96,147 $93,133.89 -$3,013.11 -3.13%